Deepeye Medical secures €2.5 million from investors to strengthen AI platform for eye health
Summary
Bayern Kapital is investing EUR 2.5 million in deepeye Medical, a start-up that is revolutionizing retinal therapy with AI. Deepeye Medical is dedicated to improving retinal therapy with the help of artificial intelligence (AI). The algorithm has learned from hundreds of thousands of retinal scans and provides data-based information to better assess disease activity and progression. It also facilitates patient education.Deepeye Medical has already achieved success in collaboration with major pharmaceutical companies such as Novartis, Bayer and Roche. With a portfolio of over 100 companies, Bayern Kapital has already supported numerous success stories and makes a significant contribution to the creation of jobs in sustainable sectors.
Funding
Review available funding amount, funding date, investors, and linked company information related to Deepeye Medical secures €2.5 million from investors to strengthen AI platform for eye health in the interactive ISVWorld profile.